Economic and clinical impact of a novel, light-based, at-home antiviral treatment on mild-to-moderate COVID-19-Reference-Cited by-同舟云学术

Economic and clinical impact of a novel, light-based, at-home antiviral treatment on mild-to-moderate COVID-19

Published:2022-04-09 Issue:1 Volume:25 Page:503-514
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Gibson Scott¹,Saunders Rhodri¹,Stasko Nathan²,Bickerstaff Cherrishe-Brown³,Oakley John²,Osterman Mark²,Torres Rafael Torrejon¹,Kish Jonathan K.³,Feinberg Bruce A.³,Emerson David²

Affiliation:

1. Coreva Scientific, Koenigswinter, Germany

2. EmitBio, Inc, Durham, NC, USA

3. Cardinal Health Specialty Solutions, Dublin, OH, USA

Funder

EmitBio, Inc

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2022.2055370

Reference49 articles.

1. Centers for Disease Control and Prevention. COVID data tracker. [cited 2022 Feb 1]. https://covid.cdc.gov/covid-data-tracker/#datatracker-home.

2. Institute for Health Metrics and Evaluation. New COVID-19 Projections. September 30, 2021. [cited 2021 Oct 1]. http://www.healthdata.org/covid/video/insights-ihmes-latest-covid-19-model-run.

3. Beyond Omicron: what’s next for COVID’s viral evolution

4. Marist Poll. NPR/PBS newshour/marist national poll: COVID. [2021; cited 2021 Oct 1]. https://maristpoll.marist.edu/polls/npr-pbs-newshour-marist-national-poll-covid-september-3-2021/.

5. Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons Learned from Model-based Economic Evaluations of COVID-19 Drug Treatments Under Pandemic Circumstances: Results from a Systematic Review;PharmacoEconomics;2024-05-10